Arecor Ltd, the UK-based specialty pharmaceutical company that develops superior biopharmaceuticals through the application of an innovative formulation technology platform, is pleased to announce today that its executive management team, Dr Sarah Howell (Chief Executive Officer) and Dr Jan Jezek (Chief Scientific Officer) will be attending the 37th Annual J.P. Morgan Healthcare Conference, San Francisco, CA.  

Timing and location details are below:

  • The 37th Annual J.P. Morgan Healthcare Conference and will be held January 7-10, 2019 at the Westin St. Francis Hotel, 335 Powell St, San Francisco, CA., US

Arecor will be available for one-on-one meetings and gladly welcomes the opportunity to discuss in more detail, both the Company’s clinical-stage portfolio of proprietary products that will enable improved treatments for diabetes, in addition to partnering opportunities within its technology business, in which the Company partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.

To arrange a one-on-one meeting with Arecor’s management team in San Francisco, please contact:

Maggie McConnell

Office Manager/PA

Tel: +44 (0)1223 426060


For more information about Arecor please go to